TM

Timothy L. Macdonald

UV University of Virginia: 53 patents #1 of 1,170Top 1%
IF International Flavors & Fragrances: 4 patents #156 of 483Top 35%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
AB AbbVie: 1 patents #860 of 1,308Top 70%
CA Cavion: 1 patents #8 of 9Top 90%
📍 Charlottesville, VA: #6 of 1,304 inventorsTop 1%
🗺 Virginia: #171 of 34,511 inventorsTop 1%
Overall (All Time): #36,940 of 4,157,543Top 1%
62
Patents All Time

Issued Patents All Time

Showing 26–50 of 62 patents

Patent #TitleCo-InventorsDate
7875595 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler +1 more 2011-01-25
7820703 Lysophosphatidic acid receptor selective antagonists Kevin R. Lynch, Brian H. Heasley 2010-10-26
7786173 Tetralin analogs having sphingosine 1-phosphate agonist activity Kevin R. Lynch 2010-08-31
7754703 Cycloalkane-containing sphingosine 1-phosphate agonists Kevin R. Lynch 2010-07-13
7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof Joel M. Linden, Jayson M. Rieger, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler 2010-06-15
7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists Kevin R. Lynch 2009-12-29
7605143 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler 2009-10-20
7576069 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler +1 more 2009-08-18
7560477 Compounds active in sphingosine 1-phosphate signaling Kevin R. Lynch 2009-07-14
7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors Joel M. Linden, Lauren J. Murphree, Mahendra D. Chordia 2009-02-03
7442687 2-polycyclic propynyl adenosine analogs having A2A agonist activity Jayson M. Rieger, Joel M. Linden, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler +1 more 2008-10-28
7396825 Agonists of A2A adenosine receptors for treatment of diabetic nephropathy Mark D. Okusa, Joel M. Linden, Alaa S. AWAD 2008-07-08
7347825 Device and method for assessing asthma and other diseases John W. Vaughan, John F. Hunt, Benjamin Gaston 2008-03-25
7241790 Compounds active in spinigosine 1-phosphate signaling Kevin R. Lynch 2007-07-10
7226913 Pharmaceutical compositions having A2A adenosine receptor agonist activity Joel M. Linden, Gail W. Sullivan, Ian Sarembock, Mark D. Okusa, Irving L. Kron +1 more 2007-06-05
7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof Joel M. Linden, Jayson M. Rieger, Gail W. Sullivan, Lauren J. Murphree, Robert Alan Figler 2007-05-08
7169818 Lysophosphatidic acid receptor agonists and antagonists Kevin R. Lynch, CHRISTOPHER E. HEISE, Webster L. Santos, Mark D. Okusa 2007-01-30
7064217 Agonists and antagonists of sphingosine-1-phosphate receptors Kevin R. Lynch 2006-06-20
6946475 Anticancer calcium channel blockers Lloyd S. Gray, Doris M. Haverstick, Tiffany Heady 2005-09-20
6759402 Cyclic felbamate derived compounds Thomas Miller, Charles D. Thompson, Christine Dieckhaus 2004-07-06
6670334 Method and compositions for treating the inflammatory response Joel M. Linden, Jayson M. Rieger, Gail W. Sullivan 2003-12-30
6599935 Felbamate derived compounds 2003-07-29
6538024 Felbamate derived compounds Thomas Miller, Charles D. Thompson, Christine Dieckhaus 2003-03-25
6531457 Methods and compositions for treating inflammatory response Joel M. Linden, Gail W. Sullivan, Ian Sarembock, Mark D. Okusa, Irving L. Kron +1 more 2003-03-11
6322771 Induction of pharmacological stress with adenosine receptor agonists Joel M. Linden, David K. Glover, George A. Beller 2001-11-27